Abstract

A major driver of neuronal hyperexcitability is dysfunction of K+ channels, including voltage-gated KCNQ2/3 channels. Their hyperpolarized midpoint of activation and slow activation and deactivation kinetics produce a current that regulates membrane potential and impedes repetitive firing. Inherited mutations in KCNQ2 and KCNQ3 are linked to a wide spectrum of neurodevelopmental disorders (NDDs), ranging from benign familial neonatal seizures to severe epileptic encephalopathies and autism spectrum disorders. However, the impact of these variants on the molecular mechanisms underlying KCNQ3 channel function remains poorly understood and existing treatments have significant side effects. Here, we use voltage clamp fluorometry, molecular dynamic simulations, and electrophysiology to investigate NDD-associated variants in KCNQ3 channels. We identified two distinctive mechanisms by which loss– and gain–of function NDD-associated mutations in KCNQ3 affect channel gating: one directly affects S4 movement while the other changes S4-to-pore coupling. MD simulations and electrophysiology revealed that polyunsaturated fatty acids (PUFAs) primarily target the voltage-sensing domain in its activated conformation and form a weaker interaction with the channel’s pore. Consistently, two such compounds yielded partial and complete functional restoration in R227Q- and R236C-containing channels, respectively. Our results reveal the potential of PUFAs to be developed into therapies for diverse KCNQ3-based channelopathies.

Fatty acids restore the function of neurodevelopmental-associated KCNQ3 mutations that either disrupt channel function by directly affecting voltage sensor movement or by changing voltage sensor-to-pore coupling.

Details

Title
Lipophilic compounds restore function to neurodevelopmental-associated KCNQ3 mutations
Author
Edmond, Michaela A. 1 ; Hinojo-Perez, Andy 2 ; Efrem, Mekedlawit 3 ; Yi-Chun, Lin 3 ; Shams, Iqra 2 ; Hayoz, Sebastien 4 ; de la Cruz, Alicia 5 ; Perez Rodriguez, Marta E. 2   VIAFID ORCID Logo  ; Diaz-Solares, Maykelis 2 ; Dykxhoorn, Derek M. 6 ; Luo, Yun Lyna 3   VIAFID ORCID Logo  ; Barro-Soria, Rene 2   VIAFID ORCID Logo 

 University of Miami, Department of Medicine, Miller School of Medicine, Miami, USA (GRID:grid.26790.3a) (ISNI:0000 0004 1936 8606); Department of Neuroscience & Experimental Therapeutics, Texas A&M University Health Science Center, Bryan, USA (GRID:grid.264756.4) (ISNI:0000 0004 4687 2082) 
 University of Miami, Department of Medicine, Miller School of Medicine, Miami, USA (GRID:grid.26790.3a) (ISNI:0000 0004 1936 8606) 
 Western University of Health Sciences, Department of Biotechnology and Pharmaceutical Sciences, College of Pharmacy, Pomona, USA (GRID:grid.268203.d) (ISNI:0000 0004 0455 5679) 
 University of Miami, Department of Medicine, Miller School of Medicine, Miami, USA (GRID:grid.26790.3a) (ISNI:0000 0004 1936 8606); University of Arizona, Department of Physiology, Tucson, USA (GRID:grid.134563.6) (ISNI:0000 0001 2168 186X) 
 University of Miami, Department of Medicine, Miller School of Medicine, Miami, USA (GRID:grid.26790.3a) (ISNI:0000 0004 1936 8606); Department of Biomedical and Clinical Sciences (BKV), Linkoping University, Linkoping, Sweden (GRID:grid.5640.7) (ISNI:0000 0001 2162 9922) 
 University of Miami, John P. Hussman Institute for Human Genomics, John T. Macdonald Foundation Department of Human Genetics, Miller School of Medicine, Miami, USA (GRID:grid.26790.3a) (ISNI:0000 0004 1936 8606) 
Pages
1181
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
23993642
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
3106879022
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.